Non-invasive administration of poractant-α in neonatal respiratory distress syndrome via a supraglottic device in the clinical practice in a second level neonatal unit: comparison of LMA® vs iGel® devices.: Non-invasive administration of poractant-α in NRDS. (2022). Acta Biomedica Atenei Parmensis, 93(1), e2022045. https://doi.org/10.23750/abm.v93i1.11649